Sars-cov-2 mrna-1273 (6m-5y) vaccine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with sars-cov-2 mrna-1273 (6m-5y) vaccine
H
- H.P. Acthar Gel (corticotropin)
- Hadlima (adalimumab)
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine
- haemophilus b conjugate (prp-t) vaccine
- haemophilus b conjugate (prp-t) vaccine / meningococcal conjugate vaccine
- Halaven (eribulin)
- Havrix (hepatitis a adult vaccine)
- Havrix Pediatric (hepatitis a pediatric vaccine)
- Hecoria (tacrolimus)
- Hemady (dexamethasone)
- hepatitis a adult vaccine
- hepatitis a adult vaccine / hepatitis b adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- Heplisav-B (hepatitis b adult vaccine)
- Hepzato (melphalan)
- Herceptin (trastuzumab)
- Herceptin Hylecta (hyaluronidase / trastuzumab)
- Hercessi (trastuzumab)
- Herzuma (trastuzumab)
- Hexadrol (dexamethasone)
- Hexalen (altretamine)
- Hiberix (haemophilus b conjugate (prp-t) vaccine)
- HibTITER (haemophilus b conjugate (hboc) vaccine)
- HiDex (dexamethasone)
- Hulio (adalimumab)
- human papillomavirus vaccine
- Humira (adalimumab)
- hyaluronan
- hyaluronan / lidocaine
- hyaluronidase / pertuzumab / trastuzumab
- hyaluronidase / rituximab
- hyaluronidase / trastuzumab
- Hycamtin (topotecan)
- Hydeltra-TBA (prednisolone)
- Hydeltrasol (prednisolone)
- Hydrea (hydroxyurea)
- hydrocortisone
- Hydrocortone (hydrocortisone)
- Hydrocortone Phosphate (hydrocortisone)
- hydroxyurea
- Hyftor (sirolimus topical)
- Hymovis (hyaluronan)
- Hyrimoz (adalimumab)
More about sars-cov-2 mrna-1273 (6m-5y) vaccine
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.